forecast
MDMA for PTSD likely first FDA approval
MDMA for PTSD treatment will very likely be the first psychedelic compound to cross the FDA approval threshold, possibly within two to four years, while psilocybin for depression is moving more slowly at an estimated three to five years.
forecastpending
Speaker
Roland GriffithsEvidence Quote
“the best guess would be that mdma might be approved in anywhere from two to four years and the work with depression is moving more slowly i would put that at three to five years for approval”
Created: 6/14/2026, 2:17:34 AM
Your notes
Loading notes...